The Board of Directors of Pasithea Therapeutics Corp. has authorized a buyback plan on July 20, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.061 USD | -3.79% | +6.77% | -31.61% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-31.61% | 5.28M | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- KTTA Stock
- News Pasithea Therapeutics Corp.
- Pasithea Therapeutics Corp. authorizes a Buyback Plan.